Active virus replication, strong infectivity, severe liver injury and obvious symptoms are the common characteristics of hepatitis B, big three yang at present.
E antigen positive (HBeAg) is an important sign of "Big Three Yang". The existence of E antigen shows that hepatitis B virus is highly contagious, which shows that patients with hepatitis B "big three positive" not only have strong virus replication ability in their own bodies, but also are easy to infect family, friends and the outside world during this period. During this period, the patient's tableware must be disinfected and isolated to prevent others from touching the patient's blood, menstrual blood, sweat and milk. For patients with hepatitis B, it is necessary to treat them in time and early during this period, remove a large number of hepatitis B viruses from the body, promote the negative conversion of E antigen or small three-positive, and reduce infectivity.
Besides infectivity, Big Three Yang also caused great damage to the liver. The continuous replication of the virus in patients will cause progressive fragmentation and necrosis of hepatocytes, damage to the structure of hepatic lobules and liver dysfunction. It is worth noting that most patients with "Big Three Yang" will develop cirrhosis after abnormal liver function.
Early treatment and removal of the virus is the only way to make the three yang gradually turn negative.
Patients with big three yang are more likely to turn negative than patients with small three yang. Because HBeAg(e antigen) is an important symbol of big three-yang, it is the key to treat big three-yang hepatitis B. Generally, patients with big three-yang and Yang can take medicine to remove the virus and gradually control the excessive growth and reproduction of hepatitis B virus, that is, control the replication degree of hepatitis B virus, and promote the transformation of E antigen into negative or small three-yang. In 2002, the first batch of liver drugs was included in the key project of "Healthy Golden Bridge". Quick? For example, some "three positive" patients turn negative directly after taking it for 6 ~ 8 months, indicating that the course of infection is shortened, and the replication of hepatitis B virus has basically stopped and entered the recovery period. If HBV-DNA is negative, it can be basically cured after taking it for 3 ~ 5 months. Some patients changed from "big three-yang" to "small three-yang" after taking medicine for 6 ~ 9 months or longer, indicating that the replication of hepatitis B virus in patients was controlled, the infectivity was weakened from strong to weak, and the harm caused by the virus to patients' liver was relatively greatly reduced. After treatment, the patients who changed from big three-yang to small three-yang still need further treatment. Because there are still a large number of hepatitis B viruses in patients at this time, it is necessary to seize the favorable period of drug action in the treatment so that the disease can be thoroughly treated.